je.st
news
Home
› OMEICOS Receives BMBF Research Grant To Advance Its Novel Approach To Treat Atrial Fibrillation
OMEICOS Receives BMBF Research Grant To Advance Its Novel Approach To Treat Atrial Fibrillation
2015-11-03 05:07:41| drugdiscoveryonline News Articles
OMEICOS Therapeutics, a biopharmaceutical company developing first-in-class small molecule therapeutics for the prevention and treatment of cardiovascular diseases including atrial fibrillation, recently announced the approval of an approximately €1.7Mgrant by the German Ministry of Education and Research (BMBF)
Tags: research
approach
advance
grant
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||